Stocks and Investing
Stocks and Investing
Thu, February 18, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, February 17, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Douglas Miehm Upgraded (BHC) to Buy and Increased Target to $42 on, Feb 17th, 2021
Douglas Miehm of RBC Capital, Upgraded "Bausch Health Companies Inc." (BHC) to Buy and Increased Target from $26 to $42 on, Feb 17th, 2021.
Douglas has made no other calls on BHC in the last 4 months.
There are 3 other peers that have a rating on BHC. Out of the 3 peers that are also analyzing BHC, 1 agrees with Douglas's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jacob Hughes of "Wells Fargo" Maintained at Hold with Decreased Target to $17 on, Wednesday, October 28th, 2020
These are the ratings of the 2 analyists that currently disagree with Douglas
- David Steinberg of "Jefferies" Maintained at Strong Buy with Increased Target to $33 on, Friday, January 15th, 2021
- David Amsellem of "Piper Sandler" Maintained at Buy with Decreased Target to $25 on, Thursday, November 5th, 2020
Contributing Sources